
# PRISMA 2020 Checklist for Long COVID Neurocognitive Systematic Review

| Section/topic | Item # | Checklist item | Reported on page # |
|---------------|--------|---------------|-------------------|
| TITLE | 1 | Identify the report as a systematic review. | Title page |
| ABSTRACT | 2 | See the PRISMA 2020 for Abstracts checklist | Abstract |
| INTRODUCTION | 3 | Explain the rationale for the review in the context of what is already known. | Introduction |
| METHODS | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses. | Methods |
| METHODS | 5 | Explain the eligibility criteria for the review. | Methods |
| METHODS | 6 | Specify the information sources (e.g. databases, registers) used to identify studies and the date last searched. | Methods |
| METHODS | 7 | Present the full search strategies for all databases, registers and websites used. | Supplementary |
| METHODS | 8 | Specify the methods used to assess risk of bias in the included studies. | Methods |
| METHODS | 9 | Specify the methods used to present and synthesize results. | Methods |
| RESULTS | 10 | Describe the results of the search and selection process. | Results |
| RESULTS | 11 | Describe the methods of data extraction from reports. | Methods |
| RESULTS | 12 | Describe the methods for assessing risk of bias in individual studies. | Methods |
| RESULTS | 13 | Specify the primary outcomes, outcome measures, effect measures, and time points reported. | Methods |
| RESULTS | 14 | Describe and appraise the sources of funding or other support. | N/A |
| RESULTS | 15 | Specify the methods used to handle missing data for each synthesis. | Methods |
| RESULTS | 16 | Describe the methods for assessing risk of bias due to missing results in a synthesis. | Methods |
| RESULTS | 17 | Describe any methods required to prepare the data for presentation or synthesis. | Methods |
| RESULTS | 18 | Describe any methods used to tabulate or visually display results of individual studies and syntheses. | Results |
| RESULTS | 19 | Summarize the characteristics and risk-of-bias assessments of the included studies. | Results, Table 1 |
| RESULTS | 20 | Summarize the main findings of the included studies. | Results |
| RESULTS | 21 | Present results of meta-analyses specifying the method used (e.g. inverse variance) to combine included studies. | Results, Forest plots |
| DISCUSSION | 22 | Discuss the limitations of the evidence included in the review. | Discussion |
| DISCUSSION | 23 | Present the overall interpretation of the results and important messages. | Discussion |
| DISCUSSION | 24 | Discuss any implications for practice and policy. | Discussion |
| OTHER | 25 | Provide a reference to the review protocol if available. | Methods |
